Palliative Care and Decision Making in Advanced Heart Failure

被引：17

作者：

LeMond L. ^{[1
]}

Camacho S.A. ^{[1
]}

Goodlin S.J. ^{[2
]}

机构：

[1] Knight Cardiovascular Institute, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, 97239, OR

[2] Oregon Health and Sciences University and VA Portland Health Care System, P3 Med, PO Box 1034, Portland, 97207-1034, OR

来源：

Current Treatment Options in Cardiovascular Medicine | 2015年 / 17卷 / 2期

关键词：

Advance directives; Advanced heart failure; Cognitive impairment; Implantable cardioverter defibrillator (ICD); Left ventricular assist device (LVAD); Palliative care;

D O I：

10.1007/s11936-014-0359-5

中图分类号：

学科分类号：

摘要：

The diagnosis of advanced heart failure (HF) is established in patients for whom symptoms are refractory to guideline-directed therapies. Palliative care (PC) is based on symptom management and support of the patient and family, making its integration into the care of those with advanced HF essential. Comorbidities including frailty, cognitive dysfunction, and depression are often under-recognized in patients with advanced HF and may correlate with outcomes. Decisions should be based on the patient’s values, goals agreed upon by the clinician with the patient, and what is medically reasonable. Palliative Care should be integrated to help with both palliation of symptoms and support for families and patients. © 2015, Springer Science+Business Media New York (outside the USA).

引用

页数：11

共 34 条

[1] Yancy C.W., Jessup M., Butler J., Et al., ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 128, pp. 240-327, (2013)
[2] Roger V.L., Go A.S., Lloyd-Jones D.M., Et al., Heart disease and stroke statistics – 2011 update: a report from the American Heart Association, Circulation, 123, 4, pp. 18-209, (2011)
[3] Lund L.H., Matthews J., Aaronson K., Patient selection for left ventricular assist devices, Eur J Heart Fail, 12, 5, pp. 434-443, (2010)
[4] Miller L.W., Left ventricular assist devices are underutilized, Circulation, 123, 14, pp. 1552-1558, (2005)
[5] Nohria A., Lewis E., Stevenson L.W., Medical Management of Advanced Heart Failure, J Am Med Assoc, 287, 5, pp. 628-640, (2002)
[6] Allen L.A., Et al., Decision Making in Advanced Heart Failure: A Scientific Statement From the American Heart Association, Circulation, 125, pp. 1928-1952, (2012)
[7] Goodlin S.J., Quill T.E., Arnold R.M., Communication and Decision-Making About Prognosis in Heart Failure Care, J Cardiac Fail, 14, pp. 106-113, (2008)
[8] Bekelman D.B., Rumsfeld J., Havranek E., Symptom Burden, Depression, and Spiritual Well-Being: A Comparison of Heart Failure and Advanced Cancer Patients, J Gen Intern Med, 24, 5, pp. 592-598, (2009)
[9] Forest S.J., Bello R., Friedmann P., Et al., Readmissions After Ventricular Assist Device: Etiologies, Patterns, and Days Out of Hospital, Ann Thorac Surg, 95, pp. 1276-1281, (2013)
[10] Levy W.C., Mozaffarian D., Linker D.T., Sutradhar S.C., Anker S.D., Cropp A.B., Et al., The Seattle Heart Failure Model: prediction of survival in heart failure, Circulation, 113, pp. 1424-1433, (2006)

← 1 2 3 4 →